Rocuronium Bromide
Injection · trading as Rocuronium
Current
FDA shortage record
- Substance
- Rocuronium Bromide
- Brand name
- Rocuronium
- Manufacturer
- Fresenius Kabi USA, LLC
- Dosage form
- Injection
- Presentation
- Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-065-05)
- Route(s)
- INTRAVENOUS
- Therapeutic category
- Anesthesia
- Package NDC
65219-065-05- Initially posted
- 02/15/2023
- Current FDA status
- Current
Reason and context
Reason reported: Delay in shipping of the drug
Next release not available at this time. Check wholesaler for inventory.
Manufacturer contact
Per the FDA record, the manufacturer's contact for supply inquiries is 888-386-1300.
If you're affected by this shortage
- Talk to your prescribing clinician or pharmacist about therapeutic alternatives. Do not switch medications on your own.
- Ask your pharmacy to check supply across multiple wholesalers and other branches.
- Check current pharmacy pricing and availability via GoodRx (affiliate link).
- Report a continuing supply problem to FDA via the FDA Drug Shortages contact form.
Sources
- FDA Drug Shortages database, accessed via the openFDA Drug Shortages API.
- FDA Structured Product Label (SPL set ID
209a654d-f92d-4242-bfef-2dcc90a30d3f). - FDA UNII identifier:
I65MW4OFHZ. - See the Drug Shortage Tracker methodology for sourcing, update cadence, normalization rules, and limits.
Important
This page reproduces publicly available FDA shortage data for informational purposes only. It is not medical advice and does not establish a clinician-patient relationship. Shortage status changes frequently; verify directly with your pharmacist or the FDA Drug Shortages site before making any treatment decision.